Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin With or Without Diffuse Pressure Wave for Adductor Spasticity in Cerebral Palsy
jRCTs051240240Recruiting
- Start
- Mar 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of botulinum toxin type A in Muscle spasm. Primary endpoint: Change in Modified Ashworth Scale (MAS) for both adductor muscles. Started Mar 2025; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
Muscle spasm
Beyond the preview
Go deeper on jRCTs051240240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051240240.